Kite, a Gilead Sciences company, recently reported new analysis showing that its CAR T therapy Yescarta delivers consistent ...

Gilead Sciences stock has seen its fair value estimate edge down only slightly, from about $130.83 to $130.63, even as the discount rate nudged up from roughly 7.26% to 7.29% and long term revenue ...

If injectable medication to prevent infection, which has gained favour across Canada, were widely available in B.C., it would ...

An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...

By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab ...

Gilead Foundation announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support services for people affected by metastatic breast ...

Malawi Greenlights Injectable HIV Prevention Drug. Malawi has become the fourth African country to greenlight lenacapavir, a ...

Viver Health is proud to announce the introduction of Your Guide to Managing Symptoms from Metastatic Breast Cancer Treatment, a take-home, evidence-based educational resource designed to help ...

South Africa, Eswatini and Zambia in December began administering a groundbreaking HIV-prevention injection in the drug's ...

(In the weekly Health Matters newsletter, Ramya Kannan writes about getting to good health, and staying there. You can ...